September 12, 2025 · Form 4 insider transaction
Parschauer Karah Herdman sold 2,450 shares of Ultragenyx Pharmaceutical Inc. at $31.17 per share, a transaction worth $76.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Includes 434 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.; Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.